Antigen-presenting cell vaccine
An antigen-presenting cell vaccine, or an APC vaccine, is a vaccine made of antigens and antigen-presenting cells (APCs).
As of March 2019[update], the only APC vaccine approved by the American Food and Drug Administration is for prostatic acid phosphatase, a commonly over-expressed prostate cancer antigen.[1][2]
References
[edit]- ^ O'Neill, David W. (November 2010). "Dendritic cells and T cells in immunotherapy". Journal of Drugs in Dermatology: JDD. 9 (11): 1383–1392. ISSN 1545-9616. PMID 21061761.
- ^ Marc S. Ernstoff; Igor Puzanov; Caroline Robert; Adi M. Diab; Peter M. Hersey (2019-03-15). SITC's Guide to Managing Immunotherapy Toxicity. Springer Publishing Company. pp. xviii. ISBN 978-0-8261-7215-0.
External links
[edit]- Antigen-presenting cell vaccine entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.
 | This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |